BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16879579)

  • 1. Ocular complications in a child with acute graft-versus-host disease following cord blood stem cell transplantation: therapeutic challenges.
    Uchino M; Ogawa Y; Kawai M; Shimada H; Kameyama K; Okamoto S; Dogru M; Tsubota K
    Acta Ophthalmol Scand; 2006 Aug; 84(4):545-8. PubMed ID: 16879579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corneal pseudomembrane from acute inflammatory response and fibrin formation to acute myeloid leukemic infiltrate.
    Kurup SK; Coleman H; Chan CC
    Am J Ophthalmol; 2005 May; 139(5):921-3. PubMed ID: 15860306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperacute graft-vs.-host disease after related HLA-identical umbilical cord blood transplantation.
    Kuskonmaz B; Gocer S; Ersoy-Ewans S; Cetin Ozman F; Cetin M; Uckan D
    Pediatr Transplant; 2007 Nov; 11(7):818-20. PubMed ID: 17910666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Unrelated umbilical cord blood transplantation as a treatment for children with malignant leukemia].
    Tang XF; Luan Z; Xu SX; Wu NH; Huang YZ; Wang K
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):5-8. PubMed ID: 18289460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophilic cystitis following cord blood transplantation: a form of acute GVHD. A variant of hemorrhagic cystitis after hematopoietic SCT or drug-induced?
    Tasaka T; Matsuhashi Y; Ohnishi H; Kubota Y
    Bone Marrow Transplant; 2008 Oct; 42(7):495-6. PubMed ID: 18604241
    [No Abstract]   [Full Text] [Related]  

  • 6. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor cell-derived acute myeloid leukemia after unrelated umbilical cord blood transplantation.
    Ando T; Yujiri T; Mitani N; Takeuchi H; Nomiyama J; Suguchi M; Matsubara A; Tanizawa Y
    Leukemia; 2006 Apr; 20(4):744-5. PubMed ID: 16437136
    [No Abstract]   [Full Text] [Related]  

  • 8. Graft rejection and hyperacute graft-versus-host disease in stem cell transplantation from non-inherited maternal-antigen-complementary HLA-mismatched siblings.
    Okumura H; Yamaguchi M; Kotani T; Sugimori N; Sugimori C; Ozaki J; Kondo Y; Yamazaki H; Chuhjo T; Takami A; Ueda M; Ohtake S; Nakao S
    Eur J Haematol; 2007 Feb; 78(2):157-60. PubMed ID: 17313562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene-expression profiles of peripheral blood mononuclear cell subpopulations in acute graft-vs-host disease following cord blood transplantation.
    Takahashi N; Sato N; Takahashi S; Tojo A
    Exp Hematol; 2008 Dec; 36(12):1760-1770. PubMed ID: 18814951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of chronic graft-versus-host disease following umbilical cord blood transplantation for adults.
    Sugimoto K; Narimatsu H; Kawase T; Iida H; Watanabe M; Kohno A; Kuwatsuka Y; Uchida T; Hamaguchi M; Terakura S; Naoe T; Matsuo K; Murata M; Sawa M; Miyamura K; Morishita Y;
    Bone Marrow Transplant; 2008 Apr; 41(8):729-36. PubMed ID: 18176617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus and methotrexate for the prophylaxis of graft-versus-host disease after unrelated donor cord blood transplantation for adult patients with hematologic malignancies.
    Mori T; Aisa Y; Nakazato T; Yamazaki R; Shimizu T; Mihara A; Yamane A; Ikeda Y; Okamoto S
    Transplant Proc; 2007 Jun; 39(5):1615-9. PubMed ID: 17580201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease.
    Lee S; Cho BS; Kim SY; Choi SM; Lee DG; Eom KS; Kim YJ; Kim HJ; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Shin WS; Kim CC
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1083-94. PubMed ID: 17697971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second transplant with two unrelated cord blood units for early graft failure after haematopoietic stem cell transplantation.
    Fernandes J; Rocha V; Robin M; de Latour RP; Traineau R; Devergie A; Ribaud P; Réa D; Larghero J; Gluckman E; Socié G
    Br J Haematol; 2007 May; 137(3):248-51. PubMed ID: 17408466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus as prophylaxis for acute graft-versus-host disease in reduced intensity cord blood transplantation for adult patients with advanced hematologic diseases.
    Miyakoshi S; Kami M; Tanimoto T; Yamaguchi T; Narimatsu H; Kusumi E; Matsumura T; Takagi S; Kato D; Kishi Y; Murashige N; Yuji K; Uchida N; Masuoka K; Wake A; Taniguchi S
    Transplantation; 2007 Aug; 84(3):316-22. PubMed ID: 17700155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chagas disease in a recipient of cord blood transplantation.
    Forés R; Sanjuán I; Portero F; Ruiz E; Regidor C; López-Vélez R; Linares M; Gil S; Ojeda E; Krsnik I; Bautista G; Vallejo C; García-Marco J; Fernández MN; Cabrera JR
    Bone Marrow Transplant; 2007 Jan; 39(2):127-8. PubMed ID: 17213850
    [No Abstract]   [Full Text] [Related]  

  • 16. [Asymmetric peripheral neuropathy following reduced-intensity cord blood transplantation].
    Sumi M; Ichikawa N; Sato S; Shimizu I; Yotsumoto M; Ueno M; Kobayashi H
    Rinsho Ketsueki; 2008 Dec; 49(12):1604-8. PubMed ID: 19110521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation].
    Lin Q; Dong M; Wang QM; Wen JY; Wu XY
    Ai Zheng; 2006 Oct; 25(10):1261-5. PubMed ID: 17059772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
    Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
    Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular surface reconstruction in graft-versus-host disease with HLA-identical living-related allogeneic cultivated limbal epithelium after hematopoietic stem cell transplantation from the same donor.
    Meller D; Fuchsluger T; Pauklin M; Steuhl KP
    Cornea; 2009 Feb; 28(2):233-6. PubMed ID: 19158575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corneal grafting and aggressive medication for corneal defects in graft-versus-host disease following bone marrow transplantation.
    Tarnawska D; Wylegała E
    Eye (Lond); 2007 Dec; 21(12):1493-500. PubMed ID: 17057649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.